Evidence map›Paper›PMID 29988561›Full record

ArticleFrontiers in neuroscience2018

Middle Cerebellar Peduncle Width-A Novel MRI Biomarker for FXTAS?

Annie L Shelton, Jun Y Wang, Emily Fourie, Flora Tassone, Anna Chen, Lauren Frizzi, Randi J Hagerman, Emilio Ferrer, David Hessl, Susan M Rivera

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Involvement of the Cerebellar Peduncles inInternational journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Annie L SheltonMIND Institute, University of California Davis Medical Center, Sacramento, CA, United States.
Jun Y WangMIND Institute, University of California Davis Medical Center, Sacramento, CA, United States.
Emily FourieMIND Institute, University of California Davis Medical Center, Sacramento, CA, United States.
Flora TassoneMIND Institute, University of California Davis Medical Center, Sacramento, CA, United States.
Anna ChenDepartment of Psychology, University of California, Davis, Davis, CA, United States.
Lauren FrizziDepartment of Psychology, University of California, Davis, Davis, CA, United States.
Randi J HagermanMIND Institute, University of California Davis Medical Center, Sacramento, CA, United States.
Emilio FerrerDepartment of Psychology, University of California, Davis, Davis, CA, United States.
David HesslMIND Institute, University of California Davis Medical Center, Sacramento, CA, United States.
Susan M RiveraMIND Institute, University of California Davis Medical Center, Sacramento, CA, United States.
University of California, Davis · USUniversity of California Davis Medical Center · US

Funding

UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
Restoring FMRP Phenotypes Frpm Temporal Regional and Splice- Isoforms VarationsP30HD002274 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 1985 to 2013
$33.6M
GENOTYPE/PHENOTYPE RELATIONSHIPS IN FRAGILE X FAMILIESR01HD036071 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI PAUL J HAGERMAN, RANDI J. HAGERMAN · 1998 to 2026
$13.8M
Rodent Behavior CoreU54HD079125 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HERTZ-PICCIOTTO, IRVA · 2013 to 2019
$8.5M
Characterization and Treatment of CNS Abnormalities in Premutation Carriers (4 ofRL1AG032115 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HAGERMAN, RANDI J. · 2007 to 2011
$5.8M
Trajectories and Markers of Neurodegeneration in Fragile X Premutation CarriersR01MH078041 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HESSL, DAVID R, RIVERA, SUSAN M · 2007 to 2017
$5.4M
Trajectories and Markers of Neurodegeneration in Fragile X Premutation CarriersR01NS110100 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DAVID R HESSL, Susan M Rivera · 2018 to 2026
$5.4M
POPULATION-BASED BIRTH DEFECTS SURVEILLANCE AND UTILAZATION OF SURVEILLANCE DATA U50DD000596 · DD · COLORADO STATE DEPT/PUB HLTH & ENVIRONMT · PI RUTTENBER, MARGARET · 2010 to 2015
$1.1M
NCATS NIH HHS UL1 TR001860NCBDD CDC HHS U50 DD000596NIA NIH HHS RL1 AG032115NICHD NIH HHS P30 HD002274NICHD NIH HHS R01 HD036071NICHD NIH HHS U54 HD079125NIMH NIH HHS R01 MH078041NINDS NIH HHS R01 NS110100
6 · The paper itself

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a severe neurodegenerative movement disorder affecting over 40% of male and 16% of female

Indexed as

biomarkersfragile XFXTASmiddle cerebellar peduncleMRI

Identifiers

PMID29988561
PMCPMC6026659
OpenAlexW2809691438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.